Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30

$3.92−0.08 (-2.00%)

Close on Nov 13, 2026Market cap $50.37MP/E –Yield –

Clene operating margin

Operating margin is operating income as a percentage of revenue.

Clene's operating margin for the twelve months ending Sep 30, 2026 was -8928.6%. For fiscal 2025 it was -11541.5%, against -9676.3% the year before. The highest annual figure on record is -6198.8% in fiscal 2023.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-11541.5%	−1865.2
FY2024	Dec 31, 2024	-9676.3%	−3477.5
FY2023	Dec 31, 2023	-6198.8%	+4035.7
FY2022	Dec 31, 2022	-10234.5%	−3321.9
FY2021	Dec 31, 2021	-6912.6%	+2900.0
FY2020	Dec 31, 2020	-9812.6%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-11333.9%	+26319.4
Q2 FY2026	Jun 30, 2026	-5941.1%	+15777.4
Q1 FY2026	Mar 31, 2026	-13740.0%	−8707.9
Q4 FY2025	Dec 31, 2025	-9733.8%	−222.8
Q3 FY2025	Sep 30, 2025	-37653.3%	−28670.6
Q2 FY2025	Jun 30, 2025	-21718.5%	−13596.5
Q1 FY2025	Mar 31, 2025	-5032.1%	+7614.5
Q4 FY2024	Dec 31, 2024	-9511.0%	−3669.8
Q3 FY2024	Sep 30, 2024	-8982.8%	−147.6
Q2 FY2024	Jun 30, 2024	-8122.0%	−4279.6
Q1 FY2024	Mar 31, 2024	-12646.6%	−2616.7
Q4 FY2023	Dec 31, 2023	-5841.2%	+33001.7
Q3 FY2023	Sep 30, 2023	-8835.2%	+35618.1
Q2 FY2023	Jun 30, 2023	-3842.4%	+3221.9
Q1 FY2023	Mar 31, 2023	-10029.9%	−529.9
Q2 FY2022	Jun 30, 2022	-38842.9%	−31989.6
Q1 FY2022	Mar 31, 2022	-44453.3%	−38962.7
Q4 FY2021	Dec 31, 2021	-7064.3%	+13487.4
Q3 FY2021	Sep 30, 2021	-9500.0%	−3692.9
Q2 FY2021	Jun 30, 2021	-6853.2%	+43824.5
Q1 FY2021	Mar 31, 2021	-5490.6%	+226.5
Q4 FY2020	Dec 31, 2020	-20551.7%	–
Q3 FY2020	Sep 30, 2020	-5807.1%	–
Q2 FY2020	Jun 30, 2020	-50677.8%	–
Q1 FY2020	Mar 31, 2020	-5717.1%	–